A
Anebulo Pharmaceuticals
ANEB
2.10000
USD
-0.278
(-11.69%)
مغلق
حجم التداول
196
الربح لكل سهم
0
العائد الربحي
0
P/E
-6
حجم السوق
47,717,119
العنوان: Anebulo Pharmaceuticals
القطاع: Healthcare
الصناعة: Biotechnology
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company. It is developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.